Catalyst OrthoScience Inc. news

Catalyst OrthoScience initiates a controlled, limited user release of the planning software to test the software in clinical settings

NAPLES, Fla., March 21, 2022 – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, today announced that the platform technology for its Archer™ 3D Targeting planning software received 510(k) clearance for use in shoulder arthroplasty. Licensed in partner